CiRA, Kyoto University and Astellas Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells ...Middle East

PR Newswire - News
CiRA, Kyoto University and Astellas Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
KYOTO, Japan and TOKYO, April 11, 2023 /PRNewswire/ -- The Center for iPS Cell Research and Application, Kyoto University (Director: Dr. Jun Takahashi; "CiRA") and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") entered into the second phase of a joint...

Hence then, the article about cira kyoto university and astellas second phase joint research agreement signed for medical applications of ips cells was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CiRA, Kyoto University and Astellas Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells )

Apple Storegoogle play

Last updated :

Also on site :